Exacerbation Rates and Healthcare Resource Utilization (HRU) in Asthma Patients Initiating Tiotropium Respimat (Tio-RMT)

To characterize real-world outcomes in asthma patients initiating Tio-RMT, a LAMA soft-mist inhaler approved for long-term maintenance treatment of asthma in patients aged ≥6 years.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research